Physician adjudication of angioedema diagnosis codes in a population of patients with heart failure prescribed angiotensin‐converting enzyme inhibitor therapy-Reference-Cited by-同舟云学术

Physician adjudication of angioedema diagnosis codes in a population of patients with heart failure prescribed angiotensin‐converting enzyme inhibitor therapy

Published:2021-10 Issue:12 Volume:30 Page:1630-1634
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Mansi Elizabeth T.¹²^ORCID,Johnson Eric S.²,Thorp Micah L.³,Go Alan S.⁴,Lee Ming‐Sum⁵,Shen Albert Yuh‐Jer⁵,Park Ken J.³,Budzynska Katarzyna⁶,Markin Abraham⁷,Sung Sue Hee⁴,Thompson Jamie H.²,Slaughter Matthew T.²,Luong Tiffany Q.⁸,An Jaejin⁸,Reynolds Kristi⁸,Roblin Douglas W.⁹,Cassidy‐Bushrow Andrea E.¹⁰,Kuntz Jennifer L.²,Schlienger Raymond G.¹¹,Behr Sigrid¹¹,Smith David H.²^ORCID

Affiliation:

1. School of Public Health University of Washington Seattle Washington USA

2. Center for Health Research, Kaiser Permanente Northwest Portland Oregon USA

3. Department of Nephrology, Kaiser Permanente Northwest Portland Oregon USA

4. Division of Research, Kaiser Permanente Northern California Oakland California USA

5. Department of Cardiology, Los Angeles Medical Center, Kaiser Permanente Southern California Los Angeles California USA

6. Department of Family Medicine, Henry Ford Hospital Detroit Michigan USA

7. Department of Emergency Medicine, Henry Ford Hospital Detroit Michigan USA

8. Department of Research and Evaluation, Kaiser Permanente Southern California Pasadena California USA

9. Mid‐Atlantic Permanente Research Institute Rockville Maryland USA

10. Department of Public Health Sciences, Henry Ford Health System Detroit Michigan USA

11. Quantitative Safety and Epidemiology, Novartis Pharma AG Basel Switzerland

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.5361

Reference10 articles.

1. Angiotensin-converting enzyme inhibitor-induced angioedema: A review of the literature

2. Angioedema Incidence in US Veterans Initiating Angiotensin-Converting Enzyme Inhibitors

3. Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema*

4. Dipeptidyl Peptidase-IV Inhibitor Use Associated With Increased Risk of ACE Inhibitor-Associated Angioedema

5. Angiotensin-Converting Enzyme Inhibitor– Associated Angioedema: From Bed to Bench